Skip to main content
Michael Leapman, MD, Urology, New Haven, CT, Yale-New Haven Hospital

MichaelStuartLeapmanMD

Urology New Haven, CT

Surgical Oncology

Physician

Overview of Dr. Leapman

Dr. Michael Leapman is an urologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital, Lawrence + Memorial Hospital, and Veterans Affairs Connecticut Healthcare System. He received his medical degree from University of Maryland School of Medicine and has been in practice 8 years. He is one of 65 doctors at Yale-New Haven Hospital and one of 15 doctors at Lawrence + Memorial Hospital who specialize in Urology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2014 - 2016
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Urology, 2010 - 2014
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 2009 - 2010
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2009

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2024
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer  
    Michael Leapman, MD, JAMA Oncology

Lectures

  • Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • More Selective Prostate Biopsy Approaches Could Greatly Reduce Health Care Pollution
    More Selective Prostate Biopsy Approaches Could Greatly Reduce Health Care PollutionMay 23rd, 2023
  • Findings from Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier
    Findings from Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic ClassifierApril 29th, 2023
  • Health Screenings Black Men Should Consider
    Health Screenings Black Men Should ConsiderFebruary 10th, 2023
  • Join now to see all

Hospital Affiliations